Torrent Pharma vs Alkem Laboratories: share price, P/E, ROE and financials compared
Torrent Pharmaceuticals
Alkem Laboratories
Torrent Pharma and Alkem Laboratories at a glance
Torrent Pharma and Alkem Laboratories are both listed in Healthcare. Torrent Pharma is the larger by market cap, at ₹1.8L Cr against ₹63,334 Cr for Alkem Laboratories (2.9 times as large). On valuation, Alkem Laboratories has the lower P/E (29.4× against 80.2×) and the lower price-to-book (4.58× against 9.83×). On returns and margins, Torrent Pharma has the higher operating margin (33.7% against 20.1%), while Alkem Laboratories has the higher ROCE (18.6% against 9.1%) and the higher ROE (17.8% against 15.7%). Over three years, Torrent Pharma has faster 3-year sales growth (+13.3% against +8.3% a year), while Alkem Laboratories has faster 3-year profit growth (+32.7% against +20.2% a year). Alkem Laboratories carries less debt for its equity, with a debt-to-equity of 0.14× against 0.77×.
Key metrics, side by side
| Metric | Torrent PharmaTORNTPHARM | Alkem LaboratoriesALKEM |
|---|---|---|
| Price (₹) | 4,750.00 | 5,297.00 |
| Market cap (₹ Cr) | 1,80,675 | 63,334 |
| P/E | 80.2× | 29.4× (the lower figure, shaded) |
| P/B | 9.83× | 4.58× (the lower figure, shaded) |
| Dividend yield, trailing | 0.80% | 1.00% (the higher figure, shaded) |
| ROE | 15.7% | 17.8% (the higher figure, shaded) |
| ROCE | 9.1% | 18.6% (the higher figure, shaded) |
| Operating margin (OPM) | 33.7% (the higher figure, shaded) | 20.1% |
| Net margin (NPM) | 12.2% | 14.3% (the higher figure, shaded) |
| Sales CAGR 3Y | +13.3% (the higher figure, shaded) | +8.3% |
| Profit CAGR 3Y | +20.2% | +32.7% (the higher figure, shaded) |
| Debt to equity | 0.77× | 0.14× (the lower figure, shaded) |
| Interest cover | 8.5× | 25.8× (the higher figure, shaded) |
| Net profit TTM (₹ Cr) | 2,124 | 2,158 |
| 1Y return | +31.7% (the higher figure, shaded) | −8.4% |
| Promoter holding | 60.78% | 49.70% |
Torrent Pharma vs Alkem Laboratories: common questions
Which is bigger, Torrent Pharma or Alkem Laboratories?
By market cap, Torrent Pharma is bigger at ₹1.8L Cr, against ₹63,334 Cr for Alkem Laboratories (prices as of 6 Nov 2026). Net profit over the last twelve months was ₹2,124 Cr for Torrent Pharma and ₹2,158 Cr for Alkem Laboratories.
Which has a lower P/E ratio, Torrent Pharma or Alkem Laboratories?
Torrent Pharma trades at a P/E of 80.2× and Alkem Laboratories at 29.4×. Alkem Laboratories has the lower P/E. P/E is the share price divided by earnings per share; it varies a lot between industries and with growth, so it says little on its own.
Which has a higher ROE, Torrent Pharma or Alkem Laboratories?
Torrent Pharma reports a return on equity of 15.7% and Alkem Laboratories 17.8%. Alkem Laboratories has the higher ROE. ROE is net profit as a share of shareholders’ equity.
Which is growing faster, Torrent Pharma or Alkem Laboratories?
Over the last three years: Sales grew +13.3% a year at Torrent Pharma and +8.3% at Alkem Laboratories, so Torrent Pharma grew sales faster; profit grew +20.2% a year at Torrent Pharma and +32.7% at Alkem Laboratories, so Alkem Laboratories grew profit faster. Past growth doesn’t predict future growth.